Have a feature idea you'd love to see implemented?
Let us know!
WINT Windtree Therapeutics Inc
Price (delayed)
$0.5093
Market cap
$301,459
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$27.73
Enterprise value
$1.87M
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset
Highlights
WINT's EPS has surged by 94% year-on-year and by 24% since the previous quarter
The company's net income has shrunk by 91% QoQ but it has surged by 53% YoY
WINT's debt has soared by 128% QoQ and by 35% YoY
Windtree Therapeutics's quick ratio has shrunk by 93% YoY and by 59% QoQ
Key stats
What are the main financial stats of WINT
Market
Valuations
Earnings
Shares outstanding
591,909
Market cap
$301,459
Enterprise value
$1.87M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.09
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$10.93M
EBITDA
-$10.44M
Free cash flow
-$12.71M
Per share
Balance sheet
Liquidity
EPS
-$27.73
Free cash flow per share
-$22.1
Book value per share
$5.9
Revenue per share
$0
TBVPS
$6.01
Total assets
$28.71M
Total liabilities
$18.26M
Debt
$3.38M
Equity
$3.49M
Working capital
-$6.72M
Debt to equity
0.97
Current ratio
0.23
Quick ratio
0.21
Net debt/EBITDA
-0.15
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-35.8%
Return on equity
-152.9%
Return on invested capital
N/A
Return on capital employed
-54.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WINT stock price
How has the Windtree Therapeutics stock price performed over time
Intraday
-0.22%
1 week
2.93%
1 month
-52.4%
1 year
-96.93%
YTD
-96.06%
QTD
-78.69%
Financial performance
How have Windtree Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.51M
Net income
-$11.38M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 91% QoQ but it has surged by 53% YoY
The operating income has contracted by 23% from the previous quarter but it has grown by 3.4% YoY
Growth
What is Windtree Therapeutics's growth rate over time
Valuation
What is Windtree Therapeutics stock price valuation
P/E
N/A
P/B
0.09
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
WINT's EPS has surged by 94% year-on-year and by 24% since the previous quarter
The price to book (P/B) is 90% less than the 5-year quarterly average of 0.9 and 85% less than the last 4 quarters average of 0.6
The equity has dropped by 77% since the previous quarter and by 70% year-on-year
Efficiency
How efficient is Windtree Therapeutics business performance
The company's return on equity has shrunk by 143% QoQ but it rose by 28% YoY
The return on assets has dropped by 109% since the previous quarter but it is up by 41% year-on-year
Dividends
What is WINT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WINT.
Financial health
How did Windtree Therapeutics financials performed over time
The company's total assets is 57% higher than its total liabilities
The current ratio has dropped by 93% year-on-year and by 66% since the previous quarter
Windtree Therapeutics's quick ratio has shrunk by 93% YoY and by 59% QoQ
WINT's debt is 3.3% lower than its equity
WINT's debt has soared by 128% QoQ and by 35% YoY
The equity has dropped by 77% since the previous quarter and by 70% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.